|
Market Closed -
Nasdaq
04:00:00 19/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.9301 USD | +5.69% |
|
+4.53% | -18.41% |
| 08-19 | IRIDEX Corporation, Q2 2026 Earnings Call, Aug 18, 2026 | |
| 08-19 | Iridex Fiscal Q2 Loss Widens, Revenue Declines | MT |
Evolution of the Average Target: IRIDEX Corporation
Evolution of the Target Price: IRIDEX Corporation
Changes in Analyst Recommendations: IRIDEX Corporation
b59da81ce800c3aa47.UXJ17tGW6cYMsh-JpperB17UKH-IG3WbcWZsB-I-8Ck.OyMzq57fo6V7_i_x6-2SPxCXT0_LeCbSFQ8ZULVGol4gGTOKmtu6glz-Lw~593d90f79920a315ea3eeecb8d8ce76f
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +212.5% | |||
| +7.84% | |||||
| +12.5% | |||||
| +22.46% | |||||
| +21.89% | |||||
| +11.18% | |||||
| +15.5% | |||||
| +7.85% | |||||
| +6.93% | |||||
| +14% | |||||
| Average | +33.27% | |||||
| Weighted average by Cap. | +13.49% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9301USD
Average target price
2.750USD
Spread / Average Target
+195.67%
High Price Target
2.750USD
Spread / Highest target
+195.67%
Low Price Target
2.750USD
Spread / Lowest Target
+195.67%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Stifel Nicolaus | |
| Roth Capital Partners |
SellBuy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9301USD
Average target price
2.750USD
Spread / Average Target
+195.67%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IRIX Stock
- Consensus IRIDEX Corporation
Select your edition
All financial news and data tailored to specific country editions
